Coffee and herbal tea consumption is associated with lower liver stiffness in the general population: The Rotterdam study

Journal of Hepatology

Volumn 67, Issue 2, 2017, Pages 339-348

  Alferink, Louise J M ^a   Fittipaldi, Juliana ^a   Kiefte de Jong, Jessica C ^a,b   Taimr, Pavel ^a   Hansen, Bettina E ^a,c   Metselaar, Herold J ^a   Schoufour, Josje D ^a   Ikram, M Arfan ^a   Janssen, Harry L A ^a,c   Franco, Oscar H ^a   Darwish Murad, Sarwa ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b LEIDEN UNIVERSITY   (Netherlands)

^c TORONTO WESTERN HOSPITAL   (Canada)

Author keywords

Coffee; General population; Herbal tea; Liver stiffness; Nutraceuticals; Steatosis

Indexed keywords

ALANINE AMINOTRANSFERASE; SODIUM CARBONATE; SUGAR;

AGE; AGED; ALCOHOL CONSUMPTION; ARTICLE; COFFEE; COHORT ANALYSIS; CROSS-SECTIONAL STUDY; FATTY LIVER; FEMALE; FOOD INTAKE; GENDER; HEALTHY DIET; HERBAL TEA; HOMEOSTASIS MODEL ASSESSMENT; HUMAN; LIVER FIBROSIS; LIVER STIFFNESS; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PHYSICAL ACTIVITY; POPULATION RESEARCH; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUESTIONNAIRE; REGRESSION ANALYSIS; SENSITIVITY ANALYSIS; SMOKING; TRANSIENT ELASTOGRAPHY; ULTRASOUND; DIAGNOSTIC IMAGING; DIET; ELASTOGRAPHY; LIVER; LIVER CIRRHOSIS; MIDDLE AGED; NETHERLANDS; STATISTICAL MODEL;

AGED; COFFEE; COHORT STUDIES; CROSS-SECTIONAL STUDIES; DIET; ELASTICITY IMAGING TECHNIQUES; FATTY LIVER; FEMALE; HUMANS; LIVER; LIVER CIRRHOSIS; LOGISTIC MODELS; MALE; MIDDLE AGED; NETHERLANDS; PROSPECTIVE STUDIES; TEAS, HERBAL;

EID: 85020097214     PISSN: 01688278     EISSN: 16000641     Source Type: Journal    
DOI: 10.1016/j.jhep.2017.03.013     Document Type: Article

References (49)

1. Lozano, R., Naghavi, M., Foreman, K., Lim, S., Shibuya, K., Aboyans, V., et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 380 (2012), 2095–2128.
2. Murray, C.J., Vos, T., Lozano, R., Naghavi, M., Flaxman, A.D., Michaud, C., et al. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 380 (2012), 2197–2223.
3. Koehler, E.M., Plompen, E.P., Schouten, J.N., Hansen, B.E., Darwish Murad, S., Taimr, P., et al. Presence of diabetes mellitus and steatosis is associated with liver stiffness in a general population: The Rotterdam study. Hepatology 63 (2016), 138–147.
4. Roulot, D., Costes, J.L., Buyck, J.F., Warzocha, U., Gambier, N., Czernichow, S., et al. Transient elastography as a screening tool for liver fibrosis and cirrhosis in a community-based population aged over 45 years. Gut 60 (2011), 977–984.
5. Wong, V.W., Chu, W.C., Wong, G.L., Chan, R.S., Chim, A.M., Ong, A., et al. Prevalence of non-alcoholic fatty liver disease and advanced fibrosis in Hong Kong Chinese: a population study using proton-magnetic resonance spectroscopy and transient elastography. Gut 61 (2012), 409–415.
6. Serfaty, L., Clinical implications of concomitant alcohol use, obesity, and viral hepatitis. Gastroenterology 150 (2016), 1718–1722.
7. Marventano, S., Salomone, F., Godos, J., Pluchinotta, F., Del Rio, D., Mistretta, A., et al. Coffee and tea consumption in relation with non-alcoholic fatty liver and metabolic syndrome: A systematic review and meta-analysis of observational studies. Clin Nutr 35 (2016), 1269–1281.
8. Yesil, A., Yilmaz, Y., Review article: coffee consumption, the metabolic syndrome and non-alcoholic fatty liver disease. Aliment Pharmacol Ther 38 (2013), 1038–1044.
9. Eskelinen, M.H., Ngandu, T., Tuomilehto, J., Soininen, H., Kivipelto, M., Midlife coffee and tea drinking and the risk of late-life dementia: a population-based CAIDE study. J Alzheimers Dis 16 (2009), 85–91.
10. Khan, N., Mukhtar, H., Tea and Health: Studies in Humans. Curr Pharm Des 19 (2013), 6141–6147.
11. Arnesen, E., Huseby, N.-E., Brenn, T., Try, K., The Tromsø Heart Study: Distribution of, and determinants for, gamma-glutamyltransferase in a free-living population. Scand J Clin Lab Invest 46 (1986), 63–70.
12. Ruhl, C.E., Everhart, J.E., Coffee and caffeine consumption reduce the risk of elevated serum alanine aminotransferase activity in the United States. Gastroenterology 128 (2005), 24–32.
13. Klatsky, A.L., Armstrong, M.A., Alcohol, smoking, coffee, and cirrhosis. Am J Epidemiol 136 (1992), 1248–1257.
14. Modi, A.A., Feld, J.J., Park, Y., Kleiner, D.E., Everhart, J.E., Liang, T.J., et al. Increased caffeine consumption is associated with reduced hepatic fibrosis. Hepatology 51 (2010), 201–209.
15. Anty, R., Marjoux, S., Iannelli, A., Patouraux, S., Schneck, A.-S., Bonnafous, S., et al. Regular coffee but not espresso drinking is protective against fibrosis in a cohort mainly composed of morbidly obese European women with NAFLD undergoing bariatric surgery. J Hepatol 57 (2012), 1090–1096.
16. Bambha, K., Wilson, L.A., Unalp, A., Loomba, R., Neuschwander-Tetri, B.A., Brunt, E.M., et al. Coffee consumption in NAFLD patients with lower insulin resistance is associated with lower risk of severe fibrosis. Liver Int 34 (2014), 1250–1258.
17. Zelber-Sagi, S., Salomone, F., Webb, M., Lotan, R., Yeshua, H., Halpern, Z., et al. Coffee consumption and nonalcoholic fatty liver onset: a prospective study in the general population. Transl Res 165 (2015), 428–436.
18. Klatsky, A.L., Morton, C., Udaltsova, N., Friedman, G.D., COffee, cirrhosis, and transaminase enzymes. Arch Intern Med 166 (2006), 1190–1195.
19. Tanaka, K., Tokunaga, S., Kono, S., Tokudome, S., Akamatsu, T., Moriyama, T., et al. Coffee consumption and decreased serum gamma-glutamyltransferase and aminotransferase activities among male alcohol drinkers. Int J Epidemiol 27 (1998), 438–443.
20. Kono, S., Shinchi, K., Imanishi, K., Todoroki, I., Hatsuse, K., Coffee and serum gamma-glutamyltransferase: a study of self-defense officials in Japan. Am J Epidemiol 139 (1994), 723–727.
21. Imai, K., Nakachi, K., Cross sectional study of effects of drinking green tea on cardiovascular and liver diseases. BMJ 310 (1995), 693–696.
22. Sakata, R., Nakamura, T., Torimura, T., Ueno, T., Sata, M., Green tea with high-density catechins improves liver function and fat infiltration in non-alcoholic fatty liver disease (NAFLD) patients: a double-blind placebo-controlled study. Int J Mol Med 32 (2013), 989–994.
23. Hofman, A., Brusselle, G.G., Darwish Murad, S., van Duijn, C.M., Franco, O.H., Goedegebure, A., et al. The Rotterdam Study: 2016 objectives and design update. Eur J Epidemiol 30 (2015), 661–708.
24. Goldbohm, R.A., van den Brandt, P.A., Brants, H.A., van't Veer, P., Al, M., Sturmans, F., et al. Validation of a dietary questionnaire used in a large-scale prospective cohort study on diet and cancer. Eur J Clin Nutr 48 (1994), 253–265.
25. Feunekes, G.I., Van Staveren, W.A., De Vries, J.H., Burema, J., Hautvast, J.G., Relative and biomarker-based validity of a food-frequency questionnaire estimating intake of fats and cholesterol. Am J Clin Nutr 58 (1993), 489–496.
26. van Lee, L., Geelen, A., van Huysduynen, E.J., de Vries, J.H., van't Veer, P., Feskens, E.J., The Dutch Healthy Diet index (DHD-index): an instrument to measure adherence to the Dutch Guidelines for a Healthy Diet. Nutr J, 11, 2012, 49.
27. Boursier, J., Zarski, J.P., de Ledinghen, V., Rousselet, M.C., Sturm, N., Lebail, B., et al. Determination of reliability criteria for liver stiffness evaluation by transient elastography. Hepatology 57 (2013), 1182–1191.
28. Wong, V.W., Vergniol, J., Wong, G.L., Foucher, J., Chan, H.L., Le Bail, B., et al. Diagnosis of fibrosis and cirrhosis using liver stiffness measurement in nonalcoholic fatty liver disease. Hepatology 51 (2010), 454–462.
29. Castera, L., Forns, X., Alberti, A., Non-invasive evaluation of liver fibrosis using transient elastography. J Hepatol 48 (2008), 835–847.
30. Hamaguchi, M., Kojima, T., Itoh, Y., Harano, Y., Fujii, K., Nakajima, T., et al. The severity of ultrasonographic findings in nonalcoholic fatty liver disease reflects the metabolic syndrome and visceral fat accumulation. Am J Gastroenterol 102 (2007), 2708–2715.
31. Grundy, S.M., Cleeman, J.I., Daniels, S.R., Donato, K.A., Eckel, R.H., Franklin, B.A., et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 112 (2005), 2735–2752.
32. Matthews, D.R., Hosker, J.P., Rudenski, A.S., Naylor, B.A., Treacher, D.F., Turner, R.C., Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28 (1985), 412–419.
33. Willett, W.C., Reynolds, R.D., Cottrell-Hoehner, S., Sampson, L., Browne, M.L., Validation of a semi-quantitative food frequency questionnaire: comparison with a 1-year diet record. J Am Diet Assoc 87 (1987), 43–47.
34. Cassinotto, C., Boursier, J., de Ledinghen, V., Lebigot, J., Lapuyade, B., Cales, P., et al. Liver stiffness in nonalcoholic fatty liver disease: A comparison of supersonic shear imaging, FibroScan, and ARFI with liver biopsy. Hepatology 63 (2016), 1817–1827.
35. Goldbohm, R.A., van 't Veer, P., van den Brandt, P.A., van 't Hof, M.A., Brants, H.A., Sturmans, F., et al. Reproducibility of a food frequency questionnaire and stability of dietary habits determined from five annually repeated measurements. Eur J Clin Nutr 49 (1995), 420–429.
36. Liu, F., Wang, X., Wu, G., Chen, L., Hu, P., Ren, H., et al. Coffee consumption decreases risks for hepatic fibrosis and cirrhosis: a meta-analysis. PLoS One, 10, 2015, e0142457.
37. Triantos C, Manolakopoulos S, Smirnidis A. Is caffeine responsible for the hepatoprotective effect of coffee consumption in patients with chronic liver diseases? A multicentre study. AASLD abstract 2013;1.
38. Molloy, J.W., Calcagno, C.J., Williams, C.D., Jones, F.J., Torres, D.M., Harrison, S.A., Association of coffee and caffeine consumption with fatty liver disease, nonalcoholic steatohepatitis, and degree of hepatic fibrosis. Hepatology 55 (2012), 429–436.
39. Ruhl, C.E., Everhart, J.E., Coffee and tea consumption are associated with a lower incidence of chronic liver disease in the United States. Gastroenterology 129 (2005), 1928–1936.
40. Honjo, S., Kono, S., Coleman, M.P., Shinchi, K., Sakurai, Y., Todoroki, I., et al. Coffee consumption and serum aminotransferases in middle-aged Japanese men. J Clin Epidemiol 54 (2001), 823–829.
41. Carlsen, M.H., Halvorsen, B.L., Holte, K., Bohn, S.K., Dragland, S., Sampson, L., et al. The total antioxidant content of more than 3100 foods, beverages, spices, herbs and supplements used worldwide. Nutr J, 9, 2010, 3.
42. Agrawal, S., Duseja, A.K., Non-alcoholic fatty liver disease: east versus west. J Clin Exp Hepatol 2 (2012), 122–134.
43. Shim, S.G., Jun, D.W., Kim, E.K., Saeed, W.K., Lee, K.N., Lee, H.L., et al. Caffeine attenuates liver fibrosis via defective adhesion of hepatic stellate cells in cirrhotic model. J Gastroenterol Hepatol 28 (2013), 1877–1884.
44. Furtado, K.S., Prado, M.G., Aguiar, E.S.M.A., Dias, M.C., Rivelli, D.P., Rodrigues, M.A., et al. Coffee and caffeine protect against liver injury induced by thioacetamide in male Wistar rats. Basic Clin Pharmacol Toxicol 111 (2012), 339–347.
45. Vitaglione, P., Morisco, F., Mazzone, G., Amoruso, D.C., Ribecco, M.T., Romano, A., et al. Coffee reduces liver damage in a rat model of steatohepatitis: the underlying mechanisms and the role of polyphenols and melanoidins. Hepatology 52 (2010), 1652–1661.
46. Rodriguez de Sotillo, D.V., Hadley, M., Sotillo, J.E., Insulin receptor exon 11+/− is expressed in Zucker (fa/fa) rats, and chlorogenic acid modifies their plasma insulin and liver protein and DNA. J Nutr Biochem 17 (2006), 63–71.
47. Xiao, J., Ho, C.T., Liong, E.C., Nanji, A.A., Leung, T.M., Lau, T.Y., et al. Epigallocatechin gallate attenuates fibrosis, oxidative stress, and inflammation in non-alcoholic fatty liver disease rat model through TGF/SMAD, PI3 K/Akt/FoxO1, and NF-kappa B pathways. Eur J Nutr 53 (2014), 187–199.
48. Nakamuta, M., Higashi, N., Kohjima, M., Fukushima, M., Ohta, S., Kotoh, K., et al. Epigallocatechin-3-gallate, a polyphenol component of green tea, suppresses both collagen production and collagenase activity in hepatic stellate cells. Int J Mol Med 16 (2005), 677–681.
49. Friedrich-Rust, M., Ong, M.F., Martens, S., Sarrazin, C., Bojunga, J., Zeuzem, S., et al. Performance of transient elastography for the staging of liver fibrosis: a meta-analysis. Gastroenterology 134 (2008), 960–974.